AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc.

Water Intelligence ( ($GB:WATR) ) has provided an update. Water Intelligence plc has executed a share buyback, purchasing 5,000 ordinary shares at ...

Water Intelligence Buys Back Shares, Updates Voting Rights

The latest announcement is out from Mattr ( ($TSE:MATR) ). Mattr Corp. has amended and extended its US$300 million senior secured revolving credit ...

Mattr Extends US$300 Million Credit Facility to 2030, Enhancing Financial Flexibility

An update from Atrys Health SA ( ($ES:ATRY) ) is now available. Atrys Health, S.A. has filed its second semi-annual financial report for 2025, cove...

Atrys Health files second semi-annual 2025 report affirming true and fair view of results

Kepler Capital analyst Julian Megias maintained a Buy rating on Atrys Health SA on March 31 and set a price target of €5.00. The company’s shares c...

Kepler Capital  Keeps Their Buy Rating on Atrys Health SA (A2T)

An announcement from Water Intelligence ( ($GB:WATR) ) is now available. Water Intelligence has executed a share buyback, acquiring 15,000 ordinary...

Water Intelligence Updates Share Capital After Latest Buyback

AtkinsRealis ( ($TSE:ATRL) ) just unveiled an announcement. AtkinsRéalis Group Inc. has launched a private offering of $700 million in unsecured de...

AtkinsRéalis to Refinance $700 Million in Debt With New Unsecured Debenture Offering

The latest announcement is out from Atrys Health SA ( ($ES:ATRY) ). Atrys Health has announced it will present its 2025 annual results in a webcast...

Atrys Health Schedules Webcast to Present 2025 Annual Results

Canaccord Genuity analyst James Wood reiterated a Buy rating on Water Intelligence yesterday and set a price target of p515.00. According to TipRan...

Water Intelligence (WATR) Gets a Buy from Canaccord Genuity

Bernstein analyst Chad Dillard maintained a Hold rating on Caterpillar yesterday and set a price target of $678.00. The company’s shares closed yes...

Bernstein Remains a Hold on Caterpillar (CAT)

AptarGroup ( ($ATR) ) has issued an announcement. On March 16, 2026, AptarGroup announced that President and CEO Stephan Tanda will retire from his...

AptarGroup Announces CEO Succession and Leadership Transition Plan

Canaccord Genuity analyst Yuri Lynk reiterated a Buy rating on Mattr today and set a price target of C$13.00. According to TipRanks, Lynk is a 5-st...

Canaccord Genuity Keeps Their Buy Rating on Mattr (MATR)

Mattr ( ($TSE:MATR) ) has shared an announcement. Mattr Corp. reported strong year-over-year growth for the fourth quarter and full year 2025, driv...

Mattr’s AmerCable-Fueled Expansion Drives Strong 2025 Profit Turnaround

The latest update is out from Atara Biotherapeutics ( ($ATRA) ). On March 12, 2026, Atara Biotherapeutics announced that it has scheduled a Type A ...

Atara Plans FDA Type A Meeting on EBVALLO

CIBC analyst Krista Friesen maintained a Buy rating on AtkinsRealis today and set a price target of C$127.00. According to TipRanks, Friesen is a 4...

AtkinsRealis (SNCAF) Receives a Buy from CIBC

Morgans analyst Annabelle Sleeman maintained a Buy rating on Astron Limited today and set a price target of A$0.90. Sleeman covers the Basic Materi...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATR	$131.40	0.00%	424.13K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATR	$131.40	0%	424.13K
3
4
5
6

ATR

ATR

No Data Available

Get AptarGroup Inc. Data in Excel

Get AptarGroup Inc. Data in Excel